Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Nierenberg, Andrew
Item TypeName
Academic Article Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Academic Article A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Academic Article Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Academic Article Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Academic Article Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
Academic Article Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Academic Article Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Academic Article Discontinuation reactions following sertraline.
Academic Article Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Academic Article A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
Concept Sertraline
Academic Article Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Search Criteria
  • Sertraline
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.